“Refractory thrombocytopenia after 177Lu-PSMA therapy: bone marrow infiltration (myelophthisis) versus treatment toxicity”, SRINMED, vol. 3, no. 1, pp. 39–46, Apr. 2026, doi: 10.37609/srinmed.63.